drugset / Trial / NCT05372380
A Study to Evaluate Drug-drug Interactions Between BR1017-1 and BR1017-2 in Healthy Volunteers
NaSequentialOpen-labelTreatment
Summary
To evaluate the influence of BR1017-1 and BR1017-2 on pharmacokinetics and safety when administered separately or co-administered to healthy volunteers.
Timeline
- Start
- 2022-05-09
- Primary completion
- 2022-06-04
- Completion
- 2022-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 40 mg | — |
| Subject | BR1017-1 | Unknown | 60 mg | — |
| Subject | Ezetimibe | Unknown | 10 mg | — |